As of June 2024 Incyte has a market cap of $13.30 Billion. This makes Incyte the world's 1294th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $13.30 B | -5.47% |
2023 | $14.07 B | -21.25% |
2022 | $17.86 B | 10.21% |
2021 | $16.21 B | -14.88% |
2020 | $19.04 B | 0.91% |
2019 | $18.87 B | 39.19% |
2018 | $13.56 B | -32.15% |
2017 | $19.98 B | 5.81% |
2016 | $18.88 B | -6.68% |
2015 | $20.24 B | 62.03% |
2014 | $12.49 B | 51.39% |
2013 | $8.25 B | 272.24% |
2012 | $2.21 B | 16.93% |
2011 | $1.89 B | -7.14% |
2010 | $2.04 B | 88.49% |
2009 | $1.08 B | 194.1% |
2008 | $0.36 B | -56.65% |
2007 | $0.84 B | 73.24% |
2006 | $0.49 B | 9.85% |
2005 | $0.44 B | -46.18% |
2004 | $0.82 B | 67.15% |
2003 | $0.49 B | 61.98% |
2002 | $0.30 B | -76.39% |
2001 | $1.29 B |
On Jun 7th, 2024 the market cap of Incyte was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novartis NVS | $217.70 B | 1,536.61% | ๐จ๐ญ Switzerland |
Pfizer PFE | $161.95 B | 1,117.46% | ๐บ๐ธ USA |
Eli Lilly LLY | $807.83 B | 5,972.84% | ๐บ๐ธ USA |
Amgen AMGN | $163.62 B | 1,130.03% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $1.46 B | -89.01% | ๐บ๐ธ USA |
Geron GERN | $2.72 B | -79.53% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $1.19 B | -90.99% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | $0.52 B | -96.08% | ๐บ๐ธ USA |
Ardelyx ARDX | $1.50 B | -88.66% | ๐บ๐ธ USA |